update on the icaria-mm trial
Published 2 years ago • 118 plays • Length 7:58Download video MP4
Download video MP3
Similar videos
-
2:12
updates from icaria-mm: longer-term efficacy data on the combination of isa-pd in r/r myeloma
-
2:25
icaria-mm: final os analysis
-
1:06
derive trial update: did vs dvd in newly diagnosed mm
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:51
the current frontline treatment strategy in multiple myeloma
-
3:46
current and emerging treatment options for lr-mds-associated anemia following esa failure
-
9:25
mgus diagnosis: a step-by-step approach
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:46
phase ii trial in progress: astx727 ± venetoclax in newly diagnosed mds/mpn
-
3:45
update on phase i trial of teclistamab in r/r myeloma
-
2:10
ikema trial update: isatuximab in mm
-
1:22
exciting upcoming mpns trials: v617f-targeted jak2 inhibitors and anti-calreticulin antibodies
-
2:00
an update on the genomic landscape of mm
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
2:57
novel targeted therapies for the treatment of bpdcn
-
1:25
the recent approval of imetelstat in lr-mds based on results of the imerge trial
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:33
updates from the ikema trial: isa-kd versus kd in r/r multiple myeloma
-
5:23
karmma-2 cohort 2b update: ide-cel for transplant-ineligible patients with high-risk myeloma